Today: 3 May 2026
Oracle stock rises as Fed minutes near; insider sale notice adds to OpenAI scrutiny
30 December 2025
2 mins read

Oracle stock rises as Fed minutes near; insider sale notice adds to OpenAI scrutiny

NEW YORK, December 30, 2025, 10:29 ET — Regular session

  • Oracle shares rose 0.8% to $197.03 in morning trading.
  • Investors are bracing for the Federal Reserve’s December meeting minutes due at 2 p.m. ET.
  • A company officer filed a Rule 144 notice for a proposed 15,000-share sale, while a Jefferies analyst flagged OpenAI-related uncertainty.

Oracle shares rose 0.8% to $197.03 in morning trading on Tuesday, recovering after a 1.3% slide in the prior session.

The move matters because Oracle is trading like a rate-sensitive, high-valuation software name, with investors using macro signals to price long-dated growth. Minutes from the Fed’s last policy meeting are expected later Tuesday, a potential catalyst for bond yields and tech multiples.

Oracle has also become a flashpoint in the market debate over AI infrastructure spending, as investors weigh whether surging demand justifies heavy upfront buildouts. Capital expenditures, or capex — money spent on long-lived assets such as data centers — has been a particular focus.

The Fed’s minutes from its December 9-10 meeting are due at 2 p.m. EST, after officials delivered a third rate cut of 2025 that took the policy range to 3.50%-3.75%, Reuters reported. The release is expected to give more detail on how divided policymakers were about the move and what it could mean for the path of rates in 2026.

Oracle traded between $194.74 and $198.34 earlier in the session, with more than 3.4 million shares changing hands by mid-morning.

A Form 144 notice posted to Oracle’s investor relations site showed Mark Hura, listed as an officer, filed to sell up to 15,000 shares under Rule 144 — an SEC rule that allows affiliates to sell restricted or “control” securities if certain conditions are met. The filing listed an aggregate market value of about $2.95 million and an approximate sale date of Dec. 24, 2025, with Fidelity Brokerage Services as broker. CloudFront

Insider sale notices are not a signal of company performance on their own, but they can add friction to sentiment when a stock is already trading on confidence in long-term projects and funding.

Jefferies analyst Brent Thill said Oracle’s outlook is tied to how investors assess the finances behind OpenAI, which is private and does not publish the kind of disclosures public-market investors are used to. “We have a little more confidence that that rich uncle is good for it,” Thill said in a CNBC interview, according to Benzinga. Benzinga

Oracle competes with Amazon’s AWS, Microsoft’s Azure and Alphabet’s Google Cloud in cloud infrastructure, and investors have been watching whether AI demand can translate into durable, profitable growth without stretching balance sheets.

Oracle’s stock has remained sensitive since the company warned earlier this month that fiscal 2026 capex would be about $15 billion higher than it had estimated in September, a shift that reignited investor debate over how quickly returns will show up from massive AI spending, Reuters reported.

Oracle’s investor relations calendar currently lists no upcoming events, keeping attention on macro drivers and any fresh disclosures on large customer commitments or financing tied to data center expansion.

For the rest of the session, traders will be watching how Oracle trades into and after the Fed minutes, with bond yields and risk appetite likely to set the tone for software and cloud shares.

Stock Market Today

  • SBI Holdings Inc: Overview of Financial Services and Business Segments
    May 3, 2026, 3:53 AM EDT. SBI Holdings Inc. operates across multiple sectors including financial services, asset management, biotechnology, and real estate. The company offers a range of finance-related services such as securities brokerage, banking, and insurance. Its asset management arm invests in innovative sectors like internet technology and environmental energy. SBI's biotechnology segment focuses on drugs, cosmetics, and health foods, while its real estate segment involves property development and online services. Founded in 1999, the Tokyo-based company spans domestic and international markets, combining traditional and cutting-edge business lines under one corporate umbrella.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 03.05.2026

3 May 2026
Rivian shares fell 8.4% to $15.02 after first-quarter results beat expectations, as investors focused on cash burn and profitability concerns. Trading volume jumped 78% above average. The company plans to ramp up R2 SUV production in Georgia to 300,000 units annually. Tesla and Lucid Group shares both rose more than 2%.
Vertiv Stock Tests AI Data-Center Rally as VRT Shares Hit Fresh Highs

Vertiv Stock Tests AI Data-Center Rally as VRT Shares Hit Fresh Highs

3 May 2026
Vertiv shares hit a 52-week high Friday before closing at $328.31, following a 30% jump in Q1 net sales to $2.65 billion. The company raised its 2026 outlook and recently acquired Strategic Thermal Labs, expanding its liquid cooling portfolio. Investors await further details at Vertiv’s May 19-20 conference in South Carolina.
AT&T Inc. Raises $6 Billion as 5G and Fiber Bet Enters a Debt Test

AT&T Inc. Raises $6 Billion as 5G and Fiber Bet Enters a Debt Test

3 May 2026
AT&T closed a $6 billion sale of long-dated notes on April 30, with maturities ranging from 2033 to 2066, according to an SEC filing. The company reported first-quarter free cash flow of $2.5 billion, down from $3.1 billion a year earlier, citing higher capital investment. AT&T is preparing to close a $23 billion purchase of EchoStar spectrum licenses. CFO Pascal Desroches said net debt to adjusted EBITDA rose to 2.71 times.
Trump Media stock slides again in premarket as DJT traders digest the fusion deal
Previous Story

Trump Media stock slides again in premarket as DJT traders digest the fusion deal

Eli Lilly stock dips after report flags China price cuts for Mounjaro
Next Story

Eli Lilly stock dips after report flags China price cuts for Mounjaro

Go toTop